Everyone is still hating on Valeant with their Bearish smack. Yeah let's be honest it hasn't been easy these past months. But let's have a bullish outlook on Allergan... yeah guess what heads. They're $42.7 Billion Dollars in Debt, way more than Valeant. And they have less cash on hand. Specifically, Valeant's has $1.4 Billion in cash and $30.9 billion in debt, a 21.46 ratio, but Allergan only has $1.1 billion in cash and $42.7 Billion in debt, a ratio of 38.5. Now let's remind ourselves Pfizer offered 160 Billion to buyout Allergan out.
VRX haters be up in this post
Submitted June 20, 2016 at 06:45PM by LordGivenchy http://ift.tt/28Kv0SH
No comments:
Post a Comment